In one paragraphArticle in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
16 authors.
Madeline Wood AlexanderHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.ORCID 0000-0003-4598-0201 Brendan WoodHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Hamilton See-Hwee OhNash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0001-8192-7593 Veronica Augustina BotThe Phil and Penny Knight Initiative for Brain Resilience, Stanford University, Stanford, CA, USA.ORCID 0009-0008-5060-1142 Julia BorgerEdward and Pearl Fein Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, California, USA.
Francesca GalbiatiCalifornia Center for Pituitary Disorders, University of California, San Francisco, California, USA.ORCID 0000-0003-0744-2541 Keenan A WalkerLaboratory of Behavioral Neuroscience, National Institute on Aging, Baltimore, MD, US.ORCID 0000-0002-5989-9853 Susan M ResnickLaboratory of Behavioral Neuroscience, National Institute on Aging, Baltimore, MD, US.ORCID 0000-0003-1115-7145 Heather M Ochs-BalcomDepartment of Epidemiology and Environmental Health, State University of New York at Buffalo, NY, USA.
Tony Wyss-CorayThe Phil and Penny Knight Initiative for Brain Resilience, Stanford University, Stanford, CA, USA.ORCID 0000-0001-5893-0831 Charles KooperbergDivision of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Emily G JacobsDepartment of Psychological & Brain Sciences, University of California, Santa Barbara, Santa Barbara, California, USA.ORCID 0000-0003-0001-5096 Jennifer S RabinHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.ORCID 0000-0003-4754-2221 Kaitlin B CasalettoEdward and Pearl Fein Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, California, USA.
Rowan SalonerEdward and Pearl Fein Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, California, USA.ORCID 0000-0002-1351-6183 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Earlier menopause is a risk factor for several age-related diseases, including dementia. The biological pathways linking menopause timing to later-life brain aging are not understood. Leveraging large-scale plasma proteomics in postmenopausal women from the UK Biobank (
Identifiers
PMID42147192
PMCPMC13174772
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390